Cancer Diagnostics Market is estimated to be US$ 46.29 billion by 2030 with a CAGR of 11.50% - By PMI
March 29, 2023 19:30 ET
|
PMI
Covina, March 29, 2023 (GLOBE NEWSWIRE) -- A CAGR of 11.50% is projected for the Cancer Diagnostics Market, which is expected to grow from US$ 1.39 billion in 2020 to US$ 46.29 billion by 2030....
Bioreactors Market is estimated to be US$ 9.5 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032) - By PMI
January 02, 2023 09:05 ET
|
PMI
Covina, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Bioreactors Market are used in production of vaccines, cell therapies, gene therapies and therapeutics. Different types of Bioreactors Markets are used for...
Biognosys Launches New Version of Spectronaut® at HUPO International Proteomics Congress
December 05, 2022 08:00 ET
|
Biognosys AG
ZURICH, Switzerland and CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch...
Biognosys lance une nouvelle version de Spectronaut® à l'occasion du congrès international de protéomique HUPO
December 05, 2022 08:00 ET
|
Biognosys AG
ZURICH, Suisse et CANCUN, Mexique, 05 déc. 2022 (GLOBE NEWSWIRE) -- Biognosys, un leader des solutions protéomiques nouvelle génération pour la recherche en sciences de la vie et le...
Biognosys stellt neue Version von Spectronaut® auf dem HUPO International Proteomics Congress vor
December 05, 2022 08:00 ET
|
Biognosys AG
ZÜRICH, Schweiz und CANCUN, Mexiko, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, ein führender Anbieter von Proteomik-Lösungen der nächsten Generation für die biowissenschaftliche Forschung und...
Biognosys lanceert nieuwe versie van Spectronaut® op HUPO International Proteomics Congress
December 05, 2022 08:00 ET
|
Biognosys AG
ZÜRICH, Zwitserland en CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, leider in next-generation proteomics-oplossingen voor lifescienceonderzoek en geneesmiddelenontwikkeling,...
Biognosys presenta la nuova versione di Spectronaut® al Congresso Internazionale di Proteomica HUPO
December 05, 2022 08:00 ET
|
Biognosys AG
ZURIGO, Svizzera e CANCÚN, Messico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, leader nelle soluzioni proteomiche di nuova generazione per la ricerca sulle scienze biologiche e lo sviluppo di...
Biognosys lanza una nueva versión de Spectronaut® en el Congreso Internacional de Proteómica de HUPO
December 05, 2022 08:00 ET
|
Biognosys AG
ZÚRICH, Suiza y CANCÚN, México, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, líder en soluciones de proteómica de última generación para la investigación en ciencias biosanitarias y...
MAKO Medical Validates Monkeypox Test from Thermo Fisher Scientific
July 11, 2022 07:10 ET
|
MAKO Medical
RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory, today announced it has validated a PCR-based monkeypox-specific assay developed by Thermo...
CGS to Moderate Session on Remote Assistance using XR at EWTS 2021
September 13, 2021 15:33 ET
|
CGS
NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- CGS, a global provider of business applications, enterprise learning and outsourcing services, today announced it will be sponsoring and moderating a...